Higher levels of fetal hemoglobin may guard against lung problems and delay bone damage in people with sickle cell disease, ...
Vertex Pharmaceuticals is scheduled to post its fourth-quarter results soon, and analysts project a double-digit earnings ...
Why Beam Therapeutics Is Back On Investors’ Radar Beam Therapeutics (BEAM) is in focus after securing U.S. FDA alignment on a ...
Ocugen has announced the publication of positive results from its phase 1 GARDian1 trial of OCU410ST, a gene therapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback